Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications
Sudesh Vasdev1, Vicki Gill, Pawan Singal
1Discipline of Medicine, Faculty of Medicine, Room H-4310, Health Sciences Centre, Memorial University of Newfoundland, St. John's, NF, A1B 3V6, Canada. svasdev@mun.ca
Insights
Insulin resistance contributes to vascular diseases like hypertension and atherosclerosis by increasing advanced glycation end products (AGEs). Therapies targeting insulin resistance and AGEs show promise in treating these conditions.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Biochemistry
Background:
- Hypertension and atherosclerosis are leading global causes of mortality.
- Both vascular diseases share insulin resistance as a common characteristic.
- Insulin resistance may be influenced by genetic and lifestyle factors.
Purpose of the Study:
- To explore the role of insulin resistance and advanced glycation end products (AGEs) in hypertension and atherosclerosis.
- To investigate potential therapeutic strategies targeting AGEs and insulin resistance.
Main Methods:
- Examined the link between insulin resistance, aldehyde production (glyoxal, methylglyoxal), and AGE formation.
- Reviewed human and animal studies on AGEs in vascular diseases.
- Assessed the efficacy of interventions that reduce insulin resistance and AGEs.
Main Results:
- Insulin resistance leads to aldehyde accumulation, forming AGEs that damage proteins.
- AGEs contribute to endothelial dysfunction, inflammation, and oxidative stress, hallmarks of hypertension and atherosclerosis.
- Studies show therapies reducing AGEs and insulin resistance improve vascular health.
Conclusions:
- Advanced glycation end products (AGEs) play a pathological role in hypertension and atherosclerosis.
- Therapies including antioxidants, AGE breakers, and lifestyle changes can mitigate these vascular diseases.
- Targeting insulin resistance and AGEs offers a novel therapeutic approach for cardiovascular conditions.
Abstract:
The vascular diseases, hypertension and atherosclerosis, affect millions of individuals worldwide, and account for a large number of deaths globally. A better understanding of the mechanism of these conditions will lead to more specific and effective therapies. Hypertension and atherosclerosis are both characterized by insulin resistance, and we suggest that this plays a major role in their etiology. The cause of insulin resistance is not known, but may be a result of a combination of genetic and lifestyle factors. In insulin resistance, alterations in glucose and lipid metabolism lead to the production of excess aldehydes including glyoxal and methylglyoxal. These aldehydes react non-enzymatically with free amino and sulfhydryl groups of amino acids of proteins to form stable conjugates called advanced glycation end products (AGEs). AGEs act directly, as well as via receptors to alter the function of many intra- and extracellular proteins including antioxidant and metabolic enzymes, calcium channels, lipoproteins, and transcriptional and structural proteins. This results in endothelial dysfunction, inflammation and oxidative stress. All these changes are characteristic of hypertension and atherosclerosis. Human and animal studies have demonstrated that increased AGEs are also associated with these conditions. A pathological role for AGEs is substantiated by studies showing that therapies that attenuate insulin resistance and/or lower AGEs, are effective in decreasing oxidative stress, lowering blood pressure, and attenuating atherosclerotic vascular changes. These interventions include lipoic acid and other antioxidants, AGE breakers or soluble receptors of AGEs, and aldehyde-binding agents like cysteine. Such therapies may offer alternative specific means to treat hypertension and atherosclerosis. An adjunct therapy may be to implement lifestyle changes such as weight reduction, regular exercise, smoking cessation, and increasing dietary intake of fruits and vegetables that also decrease insulin resistance as well as oxidative stress.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

